Patent ID: 9084805
Filing Date: 2015-07-21
Classification: A23L,A23V,A61K,A61P

Abstract:
1. A method for treating a disorder linked to an alteration of the immune system selected from the group consisting of infections, autoimmune-like diseases, innate defence disorders, cyclic neutropenia, and combinations thereof, the method comprising administering a therapeutically-effective amount of a composition containing a protein fraction comprising N-acetylneuraminic acid bound to a threonine rich peptide/protein backbone to an individual having same, the protein fraction comprises at least one glycosylated amino acid or peptide selected from the group consisting of NeuAc-α-2,3-Gal-β-1,3-(NeuAc-α-2,6-)-GalNAc-R n , NeuAc-α-2,3-Gal-β-1,3-GalNAc-R n , Gal-β-1,3-(NeuAc-α-2,6-)-GalNAc-R n , and Gal-β-1,3-GalNAc-R n , wherein R is an amino acid residue and n has a value between 1 and 10; if n has a value of 1, R is a threonine residue or a serine residue; and if n has a value of 2 to 10, the peptide contains at least one threonine or serine residue, and at least 15 mol % of the ingredient is N-acetyl-neuraminic acid.